European regulations on cord blood banking: an overview

  title={European regulations on cord blood banking: an overview},
  author={C. Petrini},
T hree EU directives (2004/23/EC, 2006/17/EC, 2006/86/EC) establish the minimum requisites of quality and safety for the donation, procurement, testing, processing, preservation, storage, and distribution of human cells in the European Union (Table 1). All the member states considered in this article have transposed the three directives into national legislation and have designated one or more competent authorities to implement them. Albeit with differences among states, the regulations for… Expand
Ethical issues in umbilical cord blood banking: a comparative analysis of documents from national and international institutions
Ethical issues including additional uses of CB samples, for example, for research or for the production of blood‐derived drugs, and the economic implications arising from the extensive international network for the exchange of CB for transplantation are examined. Expand
Umbilical cord blood banking: from personal donation to international public registries to global bioeconomy
The different types of UCBBiobank, the organization of international registries of public UCB biobanks, the optimal size of national inventories, and the possibility of obtaining commercial products from donated units are examined, with a particular emphasis on the globalized bioeconomy ofUCB and its commerciality or lack thereof. Expand
European Regulations and Ethical Issues on Cord Blood Banking
Umbilical cord blood contains hematopoietic stem cells that can be transplanted to treat numerous pathologies, mainly those affecting the blood. It can be donated to public-sector biobanks that areExpand
Umbilical cord blood banking in the worldwide hematopoietic stem cell transplantation system: perspectives for Ukraine.
The work of international and national levels of support for transplantation activity in the field of unrelated hematopoietic stem cell transplantation, the standardization order of technologies, as well as data that justify the need to create a network of donated umbilical cord blood banks in Ukraine as a factor in the development of allogeneic transplantation are analyzed. Expand
Cord Blood Banking Standards: Autologous Versus Altruistic
The regulations, standards, and accreditation schemes that are currently available nationally and internationally for public and private CB banking are explored to ensure success and the true realization of the full potential of CB. Expand
The collection of “quality” umbilical cord blood for stem cell treatments: conflicts, compromises, and clinical pragmatism
Interviews with those working on maternity wards, and in UCB collection and banking demonstrated that those most powerful in the debates are those conducting maternity practices, whilst those involved in the banking of UCB have less influence perhaps as a consequence of the lower priority of “quality”UCB collection in relation to maternal and neonatal health. Expand
Cell separation and cryopreservation of cord blood fractions for immunotherapeutic applications
Banking processes were optimised to ensure cell products retained high levels of viability and potency, and delays in cryopreservation should be minimised to <24 hours for bone marrow and <48 hours for CB and mobilised peripheral blood stem cells. Expand
Presence of hydroxy ethyl starch increases the false positive anti‐HIV test results in cord blood samples
Clinical results support the conclusion that the donor search process for allogeneic bone marrow, and UCB should be started simultaneously, and it is important that wherever possible, the number of samples used for biological determinations is the least possible. Expand
Stem Cell Banking
  • D. Ilic
  • Medicine
  • Stem Cell Biology and Regenerative Medicine
  • 2014
Stem Cell Biobanks and Long-Term Sustainability: A Swiss Working Model and Issues and Strategy for Cord Blood Banking from Ethnic Minority Groups are examined. Expand
Consideraciones éticas en torno a las diferencias entre bancos de sangre de cordón umbilical públicos y privados
Umbilical cord blood banks (CBB) were created in order to collect, analyze, store and distribute this type of biological material for the treatment of several diseases. Private CBBs store umbilicalExpand


Informed consent for cord blood donation. A theoretical and empirical study.
Most of the Italian consent forms differ significantly from the NetCord-FACT Standards, with regards both to formal and substantial aspects. Expand
Ethical issues in cord blood banking: summary of a workshop
Since technological development and clinical experience in the banking and use of cord blood is rapidly advancing, and because the National Heart, Lung, and Blood Institute recently established cord blood banks at three sites, there is an urgent need to address ethical issues. Expand
Cord blood banking: a historical perspective
Umbilical cord blood contains stem and progenitor cells capable of restoring haematopoietic and immunological function in vivo, and has been banked under stringent quality conditions, in order to ensure their safety and efficacy. Expand
Cord blood banking.
  • K. Devi
  • Medicine
  • Bulletin of the World Health Organization
  • 1998
Umbilical cord blood (UCB) contains stem cells that have already successfully treated a variety of diseases, including leukaemia, lymphomas, hemoglobinopathies, immunodeficiency, and disorders ofExpand
Banking on cord blood stem cells
Umbilical cord blood gifted to non-profit public cord blood banks is now routinely used as an alternative source of haematopoietic stem cells for allogeneic transplantation for children and adultsExpand
2013 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disorders.
Data reported herein indicate increasing use of hematopoietic cell transplants for persons with blood and bone marrow disorders and changes in transplant practices are not supported by results of large randomized trials. Expand
European Group on Ethics in Science and New Technologies.
  • Medicine
  • Human reproduction and genetic ethics
  • 1999
The rise of new health technologies are accompanied by a profound set of shifts in the way individuals engage with matters of health, and much of the promise held in these technological innovations remains to be fully realised. Expand
Public-private partnership in cord blood banking
The potential of Virgin’s combination of personal and public banking to increase storage for stem cells from cord blood is examined. Expand
Réflexions relatives au rapport d’information no 2235 de la mission parlementaire sur la révision des lois de bioéthique
RESUME A la parution du rapport d’information de la mission parlementaire consacre a la revision des lois de bioethique, l’Academie nationale de medecine a juge utile d’entreprendre une etudeExpand
Les cellules souches du cordon et du placenta: de la recherche aux applications thérapeutiques
Les questions auxquelles le groupe de travail a tente de repondre concernent les avantages scientifiques potentiels a utiliser les cellules souches du cordon and du placenta en therapie cellulaire, les risques possibles encourus, and le statut a donner aux cellules Souches ducordon. Expand